Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study

被引:50
|
作者
Kramer, Daniel B. [1 ,2 ,3 ]
Mitchell, Susan L. [1 ,2 ,3 ]
Monteiro, Joao [4 ]
Jones, Paul W. [5 ]
Normand, Sharon-Lise [2 ,6 ]
Hayes, David L. [7 ]
Reynolds, Matthew R. [8 ,9 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Hebrew SeniorLife Inst Aging Res, Boston, MA USA
[4] North Amer Sci Associates Inc, Minneapolis, MN USA
[5] Boston Sci, St Paul, MN USA
[6] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[7] Mayo Clin, Rochester, MN USA
[8] Lahey Clin Fdn, Burlington, MA USA
[9] Harvard Clin Res Inst, Boston, MA USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2015年 / 4卷 / 05期
关键词
death; implantable cardioverter-defibrillators; sudden; CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE; PHYSICAL-ACTIVITY; SHOCK THERAPY; MORTALITY; RISK; REPLACEMENT; DEVICES; VALIDATION; RECIPIENTS;
D O I
10.1161/JAHA.115.001775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Physical activity data are collected automatically by implantable cardioverter-defibrillators (ICDs). Though these data potentially provide a quantifiable and easily accessible measure of functional status, its relationship with survival has not been well studied. Methods and Results-Patients enrolled in the Boston Scientific LATITUDE remote monitoring system from 2008 to 2012 with ICDs were eligible. Remote monitoring data were used to calculate mean daily activity at baseline (30 to 60 days after implantation), and longitudinally. Cox regression was used to examine the association between survival and increments of 30 minutes/day in both (1) mean baseline activity and (2) time-varying activity, with both adjusted for demographic and device characteristics. A total of 98 437 patients were followed for a median of 2.2 years (mean age of 67.7 +/- 13.1 years; 71.7% male). Mean baseline daily activity was 107.5 +/- 66.2 minutes/day. The proportion of patients surviving after 4 years was significantly higher among those in the most versus least active quintile of mean baseline activity (90.5% vs. 50.0%; log-rank P value, <0.001). Lower mean baseline activity (i.e., incremental difference of 30-minutes/day) was independently associated with a higher risk of death (adjusted hazard ratio [AHR], 1.44; 95% confidence interval [CI], 1.427 to 1.462). Time-varying activity was similarly associated with a higher risk of death (AHR, 1.48; 95% CI, 1.451 to 1.508), indicating that a patient having 30 minutes per day less activity in a given month has a 48% increased hazard for death when compared to a similar patient in the same month. Conclusions-Patient activity measured by ICDs strongly correlates with survival following ICD implantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Al-Majed, Nawaf S.
    Ezekowitz, Justin A.
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (03) : 299 - 307
  • [32] Implantable Cardioverter-Defibrillator Implantation, Continuation, and Deactivation in Elderly Patients
    Schleifer J.W.
    Shen W.-K.
    Current Geriatrics Reports, 2017, 6 (4) : 279 - 289
  • [33] Shouldn't Everyone Have an Implantable Cardioverter-Defibrillator?
    Passman, Rod
    Kadish, Alan
    CIRCULATION, 2009, 120 (22) : 2166 - 2167
  • [34] Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study
    MacIver, Jane
    Tibbles, Alana
    Billia, Filio
    Ross, Heather
    SAGE OPEN MEDICINE, 2016, 4
  • [35] Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the National Cardiovascular Data Registry
    Kramer, Daniel B.
    Reynolds, Matthew R.
    Normand, Sharon-Lise
    Parzynski, Craig S.
    Spertus, John A.
    Mor, Vincent
    Mitchell, Susan L.
    CIRCULATION, 2016, 133 (21) : 2030 - 2037
  • [36] Implantable cardioverter-defibrillator in pregnant women with hypertrophic cardiomyopathy
    Cordeiro de Paula, Leonardo Jorge
    Ribeiro, Henrique Barbosa
    de Oliveira Junior, Roberto Marcio
    da Silva, Katia Regina
    REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2010, 25 (03): : 406 - 409
  • [37] Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study
    Kramer, Daniel B.
    Jones, Paul W.
    Rogers, Tyson
    Mitchell, Susan L.
    Reynolds, Matthew R.
    EUROPACE, 2017, 19 (11): : 1841 - 1847
  • [38] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Nawaf S. Al-Majed
    Justin A. Ezekowitz
    Current Cardiology Reports, 2012, 14 : 299 - 307
  • [39] Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter-defibrillator implantation
    Ahmed, Raheel
    Jamil, Yumna
    Ramphul, Kamleshun
    Mactaggart, Sebastian
    Bilal, Maham
    Singh Dulay, Mansimran
    Shi, Rui
    Azzu, Alessia
    Okafor, Joseph
    Memon, Rahat A.
    Sakthivel, Hemamalini
    Khattar, Rajdeep
    Wells, Athol Umfrey
    Baksi, John Arun
    Wechalekar, Kshama
    Kouranos, Vasilis
    Chahal, Anwar
    Sharma, Rakesh
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024, : 1394 - 1403
  • [40] Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
    Klein, Helmut U.
    Goldenberg, Ilan
    Moss, Arthur J.
    EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2230 - 2242